Skip to main page content
U.S. flag

An official website of the United States government

Dot gov

The .gov means it’s official.
Federal government websites often end in .gov or .mil. Before sharing sensitive information, make sure you’re on a federal government site.

Https

The site is secure.
The https:// ensures that you are connecting to the official website and that any information you provide is encrypted and transmitted securely.

Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

Filters

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

Search Results

135 results

Filters applied: . Clear all
Results are displayed in a computed author sort order. The Results By Year timeline is not available.
Page 1
Activity and safety of temozolomide in advanced adrenocortical carcinoma patients.
Cosentini D, Badalamenti G, Grisanti S, Basile V, Rapa I, Cerri S, Spallanzani A, Perotti P, Musso E, Laganà M, Ferrari VD, Luppi G, Dalla Volta A, Incorvaia L, Sigala S, Russo A, Volante M, Terzolo M, Berruti A. Cosentini D, et al. Among authors: luppi g. Eur J Endocrinol. 2019 Dec;181(6):681-689. doi: 10.1530/EJE-19-0570. Eur J Endocrinol. 2019. PMID: 31639772
The somatic affairs of BRAF: tailored therapies for advanced malignant melanoma and orphan non-V600E (V600R-M) mutations.
Ponti G, Pellacani G, Tomasi A, Gelsomino F, Spallanzani A, Depenni R, Al Jalbout S, Simi L, Garagnani L, Borsari S, Conti A, Ruini C, Fontana A, Luppi G. Ponti G, et al. Among authors: luppi g. J Clin Pathol. 2013 May;66(5):441-5. doi: 10.1136/jclinpath-2012-201345. Epub 2013 Mar 5. J Clin Pathol. 2013. PMID: 23463675 Clinical Trial.
Real-world study of everolimus in advanced progressive neuroendocrine tumors.
Panzuto F, Rinzivillo M, Fazio N, de Braud F, Luppi G, Zatelli MC, Lugli F, Tomassetti P, Riccardi F, Nuzzo C, Brizzi MP, Faggiano A, Zaniboni A, Nobili E, Pastorelli D, Cascinu S, Merlano M, Chiara S, Antonuzzo L, Funaioli C, Spada F, Pusceddu S, Fontana A, Ambrosio MR, Cassano A, Campana D, Cartenì G, Appetecchia M, Berruti A, Colao A, Falconi M, Delle Fave G. Panzuto F, et al. Among authors: luppi g. Oncologist. 2014 Sep;19(9):966-74. doi: 10.1634/theoncologist.2014-0037. Epub 2014 Aug 12. Oncologist. 2014. PMID: 25117065 Free PMC article. Clinical Trial.
A Dose-finding and Biomarker Evaluation Phase Ib Study of Everolimus in Association With 5-Fluorouracil and Pelvic Radiotherapy as Neoadjuvant Treatment of Locally Advanced Rectal Cancer (E-LARC Study).
Gelsomino F, Bertolini F, Luppi G, Spallanzani A, Pettorelli E, Reggiani Bonetti L, Meduri B, Manco G, Conte P, Cascinu S. Gelsomino F, et al. Among authors: luppi g. Clin Colorectal Cancer. 2017 Dec;16(4):410-415.e1. doi: 10.1016/j.clcc.2017.03.011. Epub 2017 Mar 24. Clin Colorectal Cancer. 2017. PMID: 28410832 Clinical Trial.
The Prognostic Role of Early Skeletal Muscle Mass Depletion in Multimodality Management of Patients with Advanced Gastric Cancer Treated with First Line Chemotherapy: A Pilot Experience from Modena Cancer Center.
Rimini M, Pecchi A, Prampolini F, Bussei C, Salati M, Forni D, Martelli F, Valoriani F, Canino F, Bocconi A, Gelsomino F, Reverberi L, Benatti S, Piacentini F, Menozzi R, Dominici M, Luppi G, Spallanzani A. Rimini M, et al. Among authors: luppi g. J Clin Med. 2021 Apr 15;10(8):1705. doi: 10.3390/jcm10081705. J Clin Med. 2021. PMID: 33921004 Free PMC article.
Irinotecan-based chemotherapy in extrapulmonary neuroendocrine carcinomas: survival and safety data from a multicentric Italian experience.
Bardasi C, Spallanzani A, Benatti S, Spada F, Laffi A, Antonuzzo L, Lavacchi D, Marconcini R, Ferrari M, Rimini M, Caputo F, Santini C, Cerma K, Casadei-Gardini A, Andrikou K, Salati M, Bertolini F, Fontana A, Dominici M, Luppi G, Gelsomino F. Bardasi C, et al. Among authors: luppi g. Endocrine. 2021 Dec;74(3):707-713. doi: 10.1007/s12020-021-02813-y. Epub 2021 Jul 6. Endocrine. 2021. PMID: 34231124
Third-line chemotherapy in advanced biliary cancers (ABC): pattern of care, treatment outcome and prognostic factors from a multicenter study.
Salati M, Rizzo A, Merz V, Messina C, Francesco C, Gelsomino F, Spallanzani A, Ricci AD, Palloni A, Frega G, De Lorenzo S, Carotenuto P, Pettorelli E, Benatti S, Luppi G, Melisi D, Brandi G, Dominici M. Salati M, et al. Among authors: luppi g. Expert Rev Gastroenterol Hepatol. 2022 Jan;16(1):73-79. doi: 10.1080/17474124.2022.2017772. Epub 2021 Dec 21. Expert Rev Gastroenterol Hepatol. 2022. PMID: 34890512
Development and Multicentre Validation of the Modena Score to Predict Survival in Advanced Biliary Cancers Undergoing Second-Line Chemotherapy.
Salati M, Marcheselli L, Messina C, Merz V, Messina M, Carotenuto P, Caputo F, Gelsomino F, Spallanzani A, Reggiani Bonetti L, Caramaschi S, Luppi G, Dominici M, Ghidini M. Salati M, et al. Among authors: luppi g. Cancer Manag Res. 2022 Mar 5;14:983-993. doi: 10.2147/CMAR.S346235. eCollection 2022. Cancer Manag Res. 2022. PMID: 35283642 Free PMC article.
Multicentre match-paired analysis of advanced biliary cancer long-term survivors: The BILONG study.
Caputo F, Gelsomino F, Spallanzani A, Pettorelli E, Benatti S, Ghidini M, Grizzi G, Ratti M, Merz V, Messina C, Tonelli R, Luppi G, Melisi D, Dominici M, Salati M. Caputo F, et al. Among authors: luppi g. Clin Res Hepatol Gastroenterol. 2022 Oct;46(8):101955. doi: 10.1016/j.clinre.2022.101955. Epub 2022 May 21. Clin Res Hepatol Gastroenterol. 2022. PMID: 35609824
135 results